Literature DB >> 26341793

Antioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbits.

Ahmed R El-Sheakh1, Hamdy A Ghoneim1, Ghada M Suddek2, El-Sayed M Ammar1.   

Abstract

Flavocoxid is a mixed extract containing baicalin and catechin, and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activity in vitro. Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models. Inflammation and oxidative stress contribute in the pathogenesis of atherosclerosis. In the present study, an experimental rabbit model of hypercholesterolemia was developed and the effects of flavocoxid were evaluated. Rabbits were divided into four groups-normal control, high-cholesterol-diet (HCD)-fed group, HCD plus flavocoxid (20 mg/kg/day), or HCD plus atorvastatin (10 mg/kg/day). Blood samples were collected at the end of the experiment for measuring serum total cholesterol (TC), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), C-reactive protein (CRP), malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD). In addition, the aorta was removed for measurement of antioxidant status, vascular reactivity, and intima/media (I/M) ratio. Elevated levels of serum TC, TGs, LDL-C, and CRP were measured in HCD group. Moreover, HCD caused a significant increase in serum and aortic MDA concomitantly with a reduction in serum and aortic GSH and SOD. Immunohistochemical staining of aortic specimens from HCD-fed rabbits revealed high expression levels of both tumor necrosis factor-alpha (TNF-α) and nuclear factor (NF)-κB. Rabbits in flavocoxid group showed significantly lower levels of serum CRP, serum, and aortic MDA and higher levels of serum HDL-C, serum, and aortic GSH and SOD compared to HCD group. HCD-induced elevations in serum TC and LDL-C did not significantly affected by flavocoxid treatment. Additionally, flavocoxid significantly enhanced rabbit aortic endothelium-dependent relaxation to acetylcholine and decreased the elevated I/M ratio. This effect was confirmed by histopathological examination of the aorta. Moreover, flavocoxid effectively suppresses the release of inflammatory markers. In conclusion, these findings demonstrated that flavocoxid would be useful in preventing oxidative stress, inflammation, and vascular dysfunction induced by HCD.

Entities:  

Keywords:  Aorta; Endothelial dysfunction; Flavocoxid; HDL-C; High-cholesterol-fed rabbits; NF-κB; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 26341793     DOI: 10.1007/s00210-015-1168-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  51 in total

Review 1.  COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.

Authors:  Garret A FitzGerald
Journal:  Nat Rev Drug Discov       Date:  2003-11       Impact factor: 84.694

2.  Hypercholesterolemia, oxidative stress and gender dependence in children.

Authors:  I Ondrejovičová; J Muchová; C Mišľanová; Z Nagyová; Z Duračková
Journal:  Prague Med Rep       Date:  2010

Review 3.  C-reactive protein in atherosclerosis: A causal factor?

Authors:  Elaine Paffen; Moniek P M DeMaat
Journal:  Cardiovasc Res       Date:  2006-03-13       Impact factor: 10.787

4.  Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression.

Authors:  Sung-Hee Park; Jung Han Yoon Park; Jung-Sook Kang; Young-Hee Kang
Journal:  Int J Biochem Cell Biol       Date:  2003-02       Impact factor: 5.085

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

7.  Agmatine ameliorates atherosclerosis progression and endothelial dysfunction in high cholesterol-fed rabbits.

Authors:  Mohammed S El-Awady; Ghada M Suddek
Journal:  J Pharm Pharmacol       Date:  2014-01-07       Impact factor: 3.765

Review 8.  Antioxidants and atherosclerotic heart disease.

Authors:  M N Diaz; B Frei; J A Vita; J F Keaney
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

Review 9.  New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.

Authors:  Fabrizio Montecucco; François Mach
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Cardioprotection against ischemia/reperfusion by licochalcone B in isolated rat hearts.

Authors:  Jichun Han; Dong Wang; Bacui Yu; Yanming Wang; Huanhuan Ren; Bo Zhang; Yonghua Wang; Qiusheng Zheng
Journal:  Oxid Med Cell Longev       Date:  2014-08-21       Impact factor: 6.543

View more
  7 in total

1.  Polymeric micelles for potentiated antiulcer and anticancer activities of naringin.

Authors:  Elham Abdelmonem Mohamed; Irhan Ibrahim Abu Hashim; Rehab Mohammad Yusif; Ahmed Abdel Aziz Shaaban; Ahmed Ramadan El-Sheakh; Mohammed Fawzy Hamed; Farid Abd Elreheem Badria
Journal:  Int J Nanomedicine       Date:  2018-02-19

2.  Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein.

Authors:  Amal Ahmed Eltobshi; Elham Abdelmonem Mohamed; Galal Mahmoud Abdelghani; Ahmed Talaat Nouh
Journal:  Int J Nanomedicine       Date:  2018-10-18

3.  Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits.

Authors:  Eman Ebrahim El Naggar; Elham Abdelmonem Mohamed; Thanaa Mohamed Borg; Ahmed Ramadan El-Sheakh; Mohammed Fawzy Hamed
Journal:  Drug Des Devel Ther       Date:  2020-02-19       Impact factor: 4.162

4.  A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy.

Authors:  Gian Luca Vita; Maria Sframeli; Norma Licata; Alessandra Bitto; Sara Romeo; Francesca Frisone; Annamaria Ciranni; Giovanni Pallio; Federica Mannino; M'Hammed Aguennouz; Carmelo Rodolico; Francesco Squadrito; Antonio Toscano; Sonia Messina; Giuseppe Vita
Journal:  Brain Sci       Date:  2021-01-16

5.  Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis.

Authors:  Bin Zhang; Juncheng Wang; Lei Du; Lufei Shao; Yourui Zou; Haibo Liu; Jinfang Liu
Journal:  J Biol Eng       Date:  2022-01-05       Impact factor: 4.355

6.  Ameliorative effect of flavocoxid on cyclophosphamide-induced cardio and neurotoxicity via targeting the GM-CSF/NF-κB signaling pathway.

Authors:  Fatma F Elsayed; Waad M Elshenawy; Eman M Khalifa; Mohamed R Rizq; Rania R Abdelaziz
Journal:  Environ Sci Pollut Res Int       Date:  2022-05-16       Impact factor: 5.190

7.  Atherosclerosis Development and Aortic Contractility in Hypercholesterolemic Rabbits Supplemented with Two Different Flaxseed Varieties.

Authors:  Jolanta Bujok; Dorota Miśta; Edyta Wincewicz; Bożena Króliczewska; Stanisław Dzimira; Magdalena Żuk
Journal:  Foods       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.